Luis A. Morales-Fernandez - Publications

Correction: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 15, 2026

Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 06, 2025

Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse.

Journal: Cancers

Published: November 20, 2024

Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study.

Journal: Melanoma research

Published: March 29, 2023

Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic.

Journal: Current oncology (Toronto, Ont.)

Published: September 15, 2022

Immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies, in a patient with melanoma treated with BRAF/MEK inhibitors.

Journal: Melanoma research

Published: May 31, 2022

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study.

Journal: Journal of the American Academy of Dermatology

Published: September 19, 2020

Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.

Journal: Journal of clinical and experimental neuropsychology

Published: November 28, 2018

Correction to: Curative radiation therapy for very elderly bladder cancer patients with localized disease.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 17, 2018

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.

Journal: Medicine

Published: February 01, 2018

Curative radiation therapy for very elderly bladder cancer patients with localized disease.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 28, 2017

Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 27, 2017